FTXH vs. PPH
Compare and contrast key facts about First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Vectors Pharmaceutical ETF (PPH).
FTXH and PPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FTXH is a passively managed fund by First Trust that tracks the performance of the Nasdaq U.S. Smart Pharmaceuticals Index. It was launched on Sep 20, 2016. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011. Both FTXH and PPH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FTXH or PPH.
Key characteristics
| FTXH | PPH | |
|---|---|---|
| YTD Return | -2.22% | 6.23% |
| 1Y Return | -2.40% | 9.71% |
| 3Y Return (Ann) | 1.00% | 9.06% |
| 5Y Return (Ann) | 5.93% | 10.50% |
| Sharpe Ratio | -0.13 | 0.96 |
| Daily Std Dev | 12.54% | 11.38% |
| Max Drawdown | -32.11% | -49.72% |
| Current Drawdown | -8.17% | -4.90% |
Correlation
The correlation between FTXH and PPH is 0.69, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
FTXH vs. PPH - Performance Comparison
In the year-to-date period, FTXH achieves a -2.22% return, which is significantly lower than PPH's 6.23% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FTXH vs. PPH - Expense Ratio Comparison
FTXH has a 0.60% expense ratio, which is higher than PPH's 0.36% expense ratio.
Risk-Adjusted Performance
FTXH vs. PPH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FTXH vs. PPH - Dividend Comparison
FTXH's dividend yield for the trailing twelve months is around 1.47%, less than PPH's 1.83% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.47% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.16% | 0.00% | 0.00% | 0.00% |
PPH VanEck Vectors Pharmaceutical ETF | 1.83% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% | 1.70% | 2.03% |
Drawdowns
FTXH vs. PPH - Drawdown Comparison
The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum PPH drawdown of -49.72%. Use the drawdown chart below to compare losses from any high point for FTXH and PPH. For additional features, visit the drawdowns tool.
Volatility
FTXH vs. PPH - Volatility Comparison
First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 3.39% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 2.90%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.